Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.
The national mammogram debate intensified this week with the release of a pair of studies that opened old wounds about the recommended frequency of preventive studies for women in their 40s.
Today the FDA cleared an adjunctive imaging technology that will give urologists an extra tool in their arsenal for the detection of prostate abnormalities.
Radiologists—and many practicing physicians—are so busy learning the clinical demands of their profession that they just don’t have time to keep up with the latest in operational needs, according to a new study.
Researchers at the University of Illinois have developed a computational method for correcting 3D tissue microscopy errors that could improve image focus without the use of adaptive hardware.
Researchers at the University of Illinois have developed a computational method for correcting 3D tissue microscopy errors that could improve image focus without the use of adaptive hardware.
In a massive cash deal announced today, imaging device maker Hologic will acquire the assets of molecular diagnostics manufacturer Gen-Probe for about $3.7 billion. The deal is expected to close by year’s end 2012.
GlobalData has released a new report, predicting big growth in hospital information systems in the emerging markets of Brazil, Russia, India, China and South America (BRICS).